Traumatic brain injury and neurodegenerative biomarkers, methods, and systems
A traumatic brain injury, biomarker technology, applied in biological testing, biological material analysis, instruments, etc., can solve the problems of high cost and difficult to obtain
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0029] Methods for diagnosing mTBI. One embodiment involves detecting the levels of biomarkers in a sample obtained from a subject and comparing the levels of these biomarkers to those of patients known to have mTBI, moderate or severe TBI, or patients without brain damage. Predetermined levels are associated. Biomarkers include one or more of the following: ubiquitin C-terminal hydrolase L1 (UCH-L1), glial markers such as glial fibrillary acidic protein (GFAP), aldehyde dehydrogenase 1 family member L1 (ALDH1L1 ) and other glial proteins, phosphorylated neurofilament heavy chain (pNFH), phosphorylated neurofilament medium chain or phosphorylated neurofilament light chain (pNFM and light chain (pNFL)), α-synuclein, opsin Like protein 1 (VILIP-1) and S100B.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com